newswire, breaking biotechnology and pharma news

Thursday, October 21, 2010 - Biotechnology Stock News; UV Flu Technologies (OTCBB: UVFT) Announces TV Segment Featuring Indoor Air Quality Biotech Products Completed and Ready for November Broadcast - Biotechnology Stock News; UV Flu Technologies (OTCBB: UVFT) Announces TV Segment Featuring Indoor Air Quality Biotech Products Completed and Ready for November Broadcast

"Designing Spaces" TV Broadcast Features Solution for Indoor Air Quality during Holiday Flu and Cold Season

CENTERVILLE, MA - October 21, 2010 ( newswire, ) Biotech stock news - UV Flu Technologies, Inc. (OTC.BB: UVFT), a developer, manufacturer and distributor of bio technology products is pleased to announce that the Company has recently completed taping a segment of the "Designing Spaces" TV Show featuring its flagship ViraTech UV-400 air purification system.

The segment will be put on air for national broadcast in late November and again in early December. The show will be aired on the Women's Entertainment channel with specific focus on holiday season health issues and is expected to reach up to 75 million households. Exact dates and times will be made available on the Company website shortly.

The theme of the segment is about staying healthy indoors over the holidays, and the UV-400 offers thought-provoking interest for health conscious consumers. The show provides insights into the UV-400's listing as a Medical Device as a result of rigorous laboratory tests which have conclusively proven that the product kills 99% of airborne bacteria in its patented UV chamber. The UV-400 is designed to easily circulate and filter the air within the average home or work environment multiple times per hour, and this will be demonstrated with real life situations and applications during the television presentation.

Given the amount of time people spend indoors during the Holidays, the show notes that not all health issues come as a result of exposure to bacteria. Many volatile compounds are regularly found in furniture, cleaning supplies, building materials, insecticides, and even common household items like hairspray. Poor indoor air quality can lead to increases in allergic reactions and other forms of respiratory problems. The alleviation of these problems will be examined and just how the UV-400 purifies the air of these irritants will be shown.

"We hope to educate people to the many dangers associated with poor indoor air quality, and also that our UV-400 is a very cost-effective way to protect themselves. We believe this show is a tremendous platform to reach one of our key markets: concerned parents who value the health of their families," stated John J. Lennon President of UV Flu Technologies.

Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

About UV Flu Technologies, Inc. (OTC.BB: UVFT)

UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The product also is highly effective in reducing odors and VOC's, or Volatile Organic Compounds, such as acetone, benzene and formaldehyde. ViraTech UV-400 is a Class II medical device and is available without a prescription.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.


UV Flu Technologies, Inc.

John J. Lennon, President & CEO


Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838

Visit the UVFT showcase profile at Request News and Info on UVFT:
Visit this company:

Disclosure, Disclaimer/ UVFT is a paid advertising client on (showcase biotech stock for one month advertising three thousand)

Published at - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

Disclaimer: The following news is paid for and /or published as information only for our readers. is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclaimer: Disclosure:

No comments:

Post a Comment